Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Br J Radiol

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NGUYEN TB, Ushinsky A, Yang A, Nguyentat M, et al
    Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
    Br J Radiol. 2018 Jun 5:20180091. doi: 10.1259/bjr.20180091.
    PubMed     Text format     Abstract available


  2. MARTIN JM, Supiot S, Keall PJ, Catton CN, et al
    Moderately hypofractionated prostate external-beam radiotherapy: an emerging standard.
    Br J Radiol. 2018;91:20170807.
    PubMed     Text format     Abstract available


    May 2018
  3. KULKARNI HR, Singh A, Langbein T, Schuchardt C, et al
    Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.
    Br J Radiol. 2018 May 15:20180308. doi: 10.1259/bjr.20180308.
    PubMed     Text format     Abstract available


  4. TIMON G, Ciardo D, Bazani A, Marvaso G, et al
    Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of phase II trial AIRC-IG-13218.
    Br J Radiol. 2018 May 11:20160725. doi: 10.1259/bjr.20160725.
    PubMed     Text format     Abstract available


    April 2018
  5. JADVAR H, Colletti PM
    (18)F-NaF/(223)RaCl2 theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcome.
    Br J Radiol. 2018 Apr 9:20170948. doi: 10.1259/bjr.20170948.
    PubMed     Text format     Abstract available


    March 2018
  6. JUNG SI, Jeon HJ, Park HS, Yu MH, et al
    Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume.
    Br J Radiol. 2018 Mar 9:20180001. doi: 10.1259/bjr.20180001.
    PubMed     Text format     Abstract available


    February 2018
  7. GODDARD L, Brodin NP, Bodner WR, Garg M, et al
    Comparing photon and proton based hypofractioned sbrt for prostate cancer accounting for robustness and realistic treatment deliverability.
    Br J Radiol. 2018 Feb 13:20180010. doi: 10.1259/bjr.20180010.
    PubMed     Text format     Abstract available


  8. KING RB, Osman SO, Fairmichael C, Irvine DM, et al
    Efficacy of a rectal spacer with prostate SABR-first UK experience.
    Br J Radiol. 2018;91:20170672.
    PubMed     Text format     Abstract available


  9. DI PAOLA V, Cybulski A, Belluardo S, Cavicchioli F, et al
    Evaluation of periprostatic neurovascular fibers before and after radical prostatectomy by means of 1.5 t mri diffusion tensor imaging.
    Br J Radiol. 2018 Feb 1:20170318. doi: 10.1259/bjr.20170318.
    PubMed     Text format     Abstract available


    January 2018

  10. Addendum to Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005; 78: S103-S111.
    Br J Radiol. 2018 Jan 31:bjr11253478a. doi: 10.1259/bjr.11253478.
    PubMed     Text format    


  11. DUFFTON A, Sadozye A, Devlin L, MacLeod N, et al
    Safety and feasibility of prostate stereotactic ablative radiotherapy using multi-modality imaging and flattening filter free.
    Br J Radiol. 2018 Jan 17:20170625. doi: 10.1259/bjr.20170625.
    PubMed     Text format     Abstract available


  12. ELFATAIRY KK, Filson CP, Sanda MG, Osunkoya AO, et al
    In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? a pilot test-retest reliability study.
    Br J Radiol. 2018 Jan 8:20170603. doi: 10.1259/bjr.20170603.
    PubMed     Text format     Abstract available


  13. TEOH EJ, McGowan DR, Schuster DM, Tsakok M, et al
    Bayesian penalised likelihood reconstruction (Q.Clear) of (18)F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.
    Br J Radiol. 2018 Jan 5:20170727. doi: 10.1259/bjr.20170727.
    PubMed     Text format     Abstract available


  14. DENIS-BACELAR AM, Chittenden SJ, McCready VR, Divoli A, et al
    Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.
    Br J Radiol. 2018 Jan 2:20170795. doi: 10.1259/bjr.20170795.
    PubMed     Text format     Abstract available


    December 2017
  15. BOUSTANI AM, Pucar D, Saperstein L
    Molecular imaging of prostate cancer.
    Br J Radiol. 2017 Dec 15:20170736. doi: 10.1259/bjr.20170736.
    PubMed     Text format     Abstract available


    November 2017
  16. BRIZMOHUN APPAYYA M, Sidhu HS, Dikaios N, Johnston EW, et al
    Characterizing indeterminate (Likert-scored 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multi-parametric MRI.
    Br J Radiol. 2017 Nov 30:20170645. doi: 10.1259/bjr.20170645.
    PubMed     Text format     Abstract available


  17. TOMITA N, Soga N, Ogura Y, Furusawa J, et al
    Effects of dose-escalated radiotherapy in combination with long-term androgen deprivation on prostate cancer.
    Br J Radiol. 2017 Nov 22:20170431. doi: 10.1259/bjr.20170431.
    PubMed     Text format     Abstract available


  18. TANAKA O, Komeda H, Tamaki M, Seike K, et al
    Comparison of MRI visualisation between linearly placed iron-containing and non-iron-containing fiducial markers for prostate radiotherapy.
    Br J Radiol. 2017 Nov 9:20170612. doi: 10.1259/bjr.20170612.
    PubMed     Text format     Abstract available


  19. PIZARRO F, Hernandez A
    Optimization of radiotherapy fractionation schedules based on radiobiological functions.
    Br J Radiol. 2017;90:20170400.
    PubMed     Text format     Abstract available


  20. CIARDO D, Jereczek-Fossa BA, Petralia G, Timon G, et al
    Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.
    Br J Radiol. 2017;90:20170021.
    PubMed     Text format     Abstract available


    August 2017
  21. KWON MR, Kim CK, Kim JH
    PI-RADS version 2: Evaluation of diffusion-weighted imaging interpretation between B = 1000 and B = 1500 s/mm2.
    Br J Radiol. 2017 Aug 22:20170438. doi: 10.1259/bjr.20170438.
    PubMed     Text format     Abstract available


    July 2017
  22. SAMLALI H, Udrescu C, Lapierre A, Enachescu C, et al
    Prospective evaluation of a specific technique of sexual function preservation in external beam radiotherapy for prostate cancer.
    Br J Radiol. 2017 Jul 27:20160877. doi: 10.1259/bjr.20160877.
    PubMed     Text format     Abstract available


  23. HAUTH E, Halbritter D, Jaeger H, Hohmuth H, et al
    Diagnostic value of semiquantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.
    Br J Radiol. 2017 Jul 27:20170067. doi: 10.1259/bjr.20170067.
    PubMed     Text format     Abstract available


  24. GERLACH S, Kuhlemann I, Ernst F, Furweger C, et al
    Impact of robotic ultrasound image guidance on plan quality in SBRT of the prostate.
    Br J Radiol. 2017 Jul 27:20160926. doi: 10.1259/bjr.20160926.
    PubMed     Text format     Abstract available


    June 2017
  25. FLUX GD
    Imaging and dosimetry for radium-223: the potential for personalized treatment.
    Br J Radiol. 2017 Jun 27:20160748. doi: 10.1259/bjr.20160748.
    PubMed     Text format     Abstract available


    May 2017
  26. GASNIER A, Parvizi N
    Updates on the diagnosis and treatment of prostate cancer.
    Br J Radiol. 2017 May 30:20170180. doi: 10.1259/bjr.20170180.
    PubMed     Text format     Abstract available


  27. ROBINSON JL, Tzou KS, Parker AS, Heckman MG, et al
    GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
    Br J Radiol. 2017 May 9:20170174. doi: 10.1259/bjr.20170174.
    PubMed     Text format     Abstract available


    March 2017
  28. YU J, Fulcher AS, Winks SG, Turner MA, et al
    Diagnosis of Typical and Atypical Transitional Zone Prostate Cancer and its Mimics at Multiparametric Prostate MRI.
    Br J Radiol. 2017 Mar 3:20160693. doi: 10.1259/bjr.20160693.
    PubMed     Text format     Abstract available


    February 2017
  29. NITSCHE M, Brannath W, Bruckner M, Wagner D, et al
    Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Br J Radiol. 2017;90:20160370.
    PubMed     Text format     Abstract available


    January 2017
  30. HARVEY H, Orton MR, Morgan VA, Parker C, et al
    Volumetry of the Dominant Intraprostatic Tumour Lesion: Intersequence and Interobserver Differences on Multiparametric MRI.
    Br J Radiol. 2017 Jan 5:20160416. doi: 10.1259/bjr.20160416.
    PubMed     Text format     Abstract available


    December 2016
  31. CHAN J, Carver A, Brunt JN, Vinjamuri S, et al
    Effect of androgen deprivation therapy on intra-prostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.
    Br J Radiol. 2016 Dec 20:20160818.
    PubMed     Text format     Abstract available


  32. ARIYARATNE H, Chesham H, Alonzi R
    Image-guided radiotherapy for prostate cancer in the United Kingdom: a national survey.
    Br J Radiol. 2016 Dec 7:20160059.
    PubMed     Text format     Abstract available


  33. O'NEILL AG, Jain S, Hounsell AR, O'Sullivan JM, et al
    Fiducial marker guided prostate radiotherapy: a review.
    Br J Radiol. 2016;89:20160296.
    PubMed     Text format     Abstract available


    November 2016
  34. LJUNGBERG M, Pretorius PH
    SPECT/CT: an update on technological developments and clinical applications.
    Br J Radiol. 2016 Nov 15:20160402.
    PubMed     Text format     Abstract available


    October 2016
  35. KATARIA T, Gupta D, Goyal S, Bisht SS, et al
    Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: An MRI based approach.
    Br J Radiol. 2016 Oct 17:20160348.
    PubMed     Text format     Abstract available


  36. ALMATANI T, Hugtenburg RP, Lewis RD, Barley SE, et al
    Automated algorithm for CBCT-based dose calculations of prostate radiotherapy with bilateral hip prostheses.
    Br J Radiol. 2016;89:20160443.
    PubMed     Text format     Abstract available


    July 2016
  37. FELLIN G, Mirri MA, Santoro L, Jereczek-Fossa BA, et al
    Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: Practice and outcome analysis in a series of 2237 patients from 11 Institutions.
    Br J Radiol. 2016 Jul 7:20150981.
    PubMed     Text format     Abstract available


  38. YARTSEV S, Bauman G
    Target margins in radiotherapy of prostate cancer.
    Br J Radiol. 2016 Jul 5:20160312.
    PubMed     Text format     Abstract available


  39. JERECZEK-FOSSA BA, Ciardo D, Ferrario S, Fossati P, et al
    No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy.
    Br J Radiol. 2016;89:20150985.
    PubMed     Text format     Abstract available


    May 2016
  40. VAN HOLSBEECK A, Degroote A, De Wever L, Vanhoutte E, et al
    Staging of prostatic carcinoma at 1.5 T MRI: correlation of a simplified MRI exam with whole mount radical prostatectomy specimens.
    Br J Radiol. 2016 May 16:20160101.
    PubMed     Text format     Abstract available



  41. Correction to MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.
    Br J Radiol. 2016;89:11253478c.
    PubMed     Text format    


    April 2016
  42. WU LM, Zhao ZZ, Chen XX, Lu Q, et al
    Comparison of T2* Mapping with Diffusion-Weighted Imaging in the Characterization of Low- vs Intermediate- and High-Grade Prostate Cancer.
    Br J Radiol. 2016 Apr 19:20151076.
    PubMed     Text format     Abstract available


    March 2016
  43. LIN WC, Muglia VF, Silva GE, Chodraui Filho S, et al
    Multiparametric Magnetic Resonance Imaging of the Prostate: Diagnostic Performance and Inter-reader Agreement of Two Scoring Systems.
    Br J Radiol. 2016 Mar 23:20151056.
    PubMed     Text format     Abstract available


  44. ISHII K, Ogino R, Hosokawa Y, Fujioka C, et al
    Comparison of dosimetric parameters and acute toxicity after whole-pelvic versus prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.
    Br J Radiol. 2016 Mar 9:20150930.
    PubMed     Text format     Abstract available


    February 2016
  45. BOONSTRA PS, Taylor JM, Smolska-Ciszewska B, Behrendt K, et al
    Alpha/beta (alpha/beta) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost.
    Br J Radiol. 2016 Feb 23:20150957.
    PubMed     Text format     Abstract available


    January 2016
  46. WONG WK, Leung LH, Kwong DL
    Evaluation and optimization of the parameters used in multiple-atlas-based segmentation of prostate cancers in radiation therapy.
    Br J Radiol. 2016;89:20140732.
    PubMed     Text format     Abstract available


  47. THOMAS SJ, Romanchikova M, Harrison K, Parker MA, et al
    Recalculation of dose for each fraction of treatment on TomoTherapy.
    Br J Radiol. 2016;89:20150770.
    PubMed     Text format     Abstract available


  48. DANISH QASEEM SM, Ghonge NP, Aggarwal B, Singhal S, et al
    Prospective evaluation of prostate with transrectal spectral Doppler with biopsy correlation: a clinicopathologic study.
    Br J Radiol. 2016;89:20150830.
    PubMed     Text format     Abstract available


    December 2015
  49. LANGMACK KA, Newton LA, Jordan S, Smith R, et al
    Cone-beam CT Dose Reduction in Prostate Radiotherapy using Likert Scale Methods.
    Br J Radiol. 2015 Dec 21:20150460.
    PubMed     Text format     Abstract available


  50. PARK SY, Kim CK, Park JJ, Park BK, et al
    Exponential apparent diffusion coefficient in evaluating prostate cancer at 3T: preliminary experience.
    Br J Radiol. 2015 Dec 10:20150470.
    PubMed     Text format     Abstract available


  51. WAHART A, Guy JB, Vallard A, Geissler B, et al
    Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-Choline for guiding target volume delineation.
    Br J Radiol. 2015 Dec 9:20150579.
    PubMed     Text format     Abstract available


    August 2015
  52. LIM C, Malone S, Avruch L, Breau R, et al
    Magnetic Resonance for radiotherapy management and treatment planning in prostatic carcinoma.
    Br J Radiol. 2015 Aug 17:20150507.
    PubMed     Text format     Abstract available


  53. HAUTH E, Hohmuth H, Cozub-Poetica C, Bernand S, et al
    Multiparametric MRI of prostate with three functional techniques in patients with PSA-elevation before initial TRUS-guided biopsy.
    Br J Radiol. 2015 Aug 13:20150422.
    PubMed     Text format     Abstract available


  54. MCNAIR HA, Harris EJ, Hansen VN, Thomas K, et al
    Magnitude of observer error using cone beam CT for prostate inter-fraction motion estimation: effect of reducing scan length or increasing exposure.
    Br J Radiol. 2015 Aug 6:20150208.
    PubMed     Text format     Abstract available


    January 2015
  55. LUPATTELLI M, Alcusky M, Aristei C, Bellavita R, et al
    Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists.
    Br J Radiol. 2015;88:20150587.
    PubMed     Text format     Abstract available


  56. MANCOSU P, Reggiori G, Gaudino A, Lobefalo F, et al
    Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions.
    Br J Radiol. 2015;88:20150468.
    PubMed     Text format     Abstract available


  57. HEIKKILA VP
    PEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluation.
    Br J Radiol. 2015;88:20150421.
    PubMed     Text format     Abstract available


  58. DASU A, Toma-Dasu I
    Will intrafraction repair have negative consequences on extreme hypofractionation in prostate radiation therapy?
    Br J Radiol. 2015;88:20150588.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: